Arterial Hypertension最新文献_第5页

Cognitive dysfunctions in patients with hypertension — pathogenesis and treatment 高血压患者认知功能障碍的发病机制及治疗

IF 0.7

Arterial Hypertension Pub Date : 2022-06-30 DOI: 10.5603/ah.a2022.0007

A. Wolska-Bułach, M. Wierzowiecka, K. Niklas, A. Tykarski, Arkadiusz A. Niklas

{"title":"Cognitive dysfunctions in patients with hypertension — pathogenesis and treatment","authors":"A. Wolska-Bułach, M. Wierzowiecka, K. Niklas, A. Tykarski, Arkadiusz A. Niklas","doi":"10.5603/ah.a2022.0007","DOIUrl":"https://doi.org/10.5603/ah.a2022.0007","url":null,"abstract":"3 mil-Abstract Memory disorders are one of the most frequent abnormalities found in the elderly. The dominant cause of the disorder is dementia of Alzheimer’s type (about 60%), vascular dementia is responsible for 15–20% of cases, and the rest are mixed forms. One of the basic symptoms is a weakening of the ability to remember. With time, dementia becomes more severe and the cognitive and mental disorders are accompanied by progressive somatic infirmity, leading in the final stage to bed immobilization and total dependence on the care of other people. Treatment of vascular dementia comes down to counteracting stroke risk factors and treating hypertension, as well as diabetes and other cardiovascular diseases. It has been clearly demonstrated that hypotensive drugs can reduce the risk of dementia. When choosing therapy for elderly patients, we should also bear in mind the effects on blood pressure and blood pressure variability, as these have been shown to be associated with a higher risk of dementia. The guidelines indicate the benefit of using a combination of a thiazide-like diuretic (indapamide) and a calcium antagonist (amlodipine) in elderly. Combination treatment with a converting enzyme inhibitor (perindopril) and a thiazide-like diuretic (indapamide) is also particularly beneficial in this age group.","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":"143 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73498458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Role of plasma 8-OXO-2’-deoxyguanosine in target organ damage in patients with hypertension and type 2 diabetes 血浆8-OXO-2′-脱氧鸟苷在高血压和2型糖尿病患者靶器官损伤中的作用

IF 0.7

Arterial Hypertension Pub Date : 2022-06-30 DOI: 10.5603/ah.a2022.0006

V. Nemtsova, A. Shalimova, O. Kolesnikova, O. Vysotska, V. Zlatkina, N. Zhelezniakova

引用次数: 0

Different faces of resistant hypertension in obesity 肥胖症中顽固性高血压的不同面貌

IF 0.7

Arterial Hypertension Pub Date : 2022-06-30 DOI: 10.5603/ah.a2022.0011

A. Shalimova

引用次数: 0

Emotion regulation and the quality of life in patients with essential hypertension: a search for psychological targets 原发性高血压患者的情绪调节和生活质量:寻找心理目标

IF 0.7

Arterial Hypertension Pub Date : 2022-06-30 DOI: 10.5603/ah.a2022.0004

Paweł Larionow

{"title":"Emotion regulation and the quality of life in patients with essential hypertension: a search for psychological targets","authors":"Paweł Larionow","doi":"10.5603/ah.a2022.0004","DOIUrl":"https://doi.org/10.5603/ah.a2022.0004","url":null,"abstract":"Background: Essential hypertension (HTN) is a chronic disease, which is associated with a reduction in the health-related quality of life (HRQoL). Most studies have examined the relationship between HRQoL and medical or sociodemographic features, whereas the implementation of tasks related to increasing the HRQoL is not possible without taking psychological factors into account. Studies highlight the importance of emotion regulation in the course and treatment of HTN as well as in the development of psychological interventions for hypertensive patients. The purpose of the study is to investigate the relationship between cognitive emotion regulation strategies and the HRQoL in hypertensive patients. Material and methods: 30 patients with HTN (21 women and 9 men) aged 44–85 (M = 64.6, SD = 10.0) were recruited in Bydgoszcz (Poland). The patients filled out the Cognitive Emotion Regulation Questionnaire and the World Health Organization Quality of Life–BREF questionnaire. Results: All maladaptive cognitive coping strategies (e.g., catastrophizing, blaming others or rumination) were not related to HRQoL, whereas most adaptive cognitive coping strategies (positive reappraisal, refocus on planning or putting into perspective) were positively correlated with the HRQoL. In particular, positive reappraisal strategy has a highly significant role for the HRQoL in hypertensive patients. Conclusions: The role of adaptive cognitive coping strategies is significant in terms of implementing appropriate psychological support, including the improvement of the HRQoL for patients with HTN. Practical applications of the study are being discussed.","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":"154 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77960855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

COVID-19 clinical outcomes in patients with and without ongoing therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers 接受和未接受血管紧张素转换酶抑制剂或血管紧张素II受体阻滞剂治疗的患者的COVID-19临床结局

IF 0.7

Arterial Hypertension Pub Date : 2022-03-31 DOI: 10.5603/AH.a2022.0005

Ahmed Nafakhi, Ihsan Rabeea, Rasha Al-Darraji, H. Nafakhi, A. Mechi, Alhan Al-khalidi

{"title":"COVID-19 clinical outcomes in patients with and without ongoing therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers","authors":"Ahmed Nafakhi, Ihsan Rabeea, Rasha Al-Darraji, H. Nafakhi, A. Mechi, Alhan Al-khalidi","doi":"10.5603/AH.a2022.0005","DOIUrl":"https://doi.org/10.5603/AH.a2022.0005","url":null,"abstract":"Background: The are conflicting reports on the effects of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB) continued treatment on clinical outcomes in COVID-19 patients. Material and methods: Patients presented with symptoms suggestive of COVID-19 infection were enrolled between 5 April 2021,and 5 June 2021. Patients who survived acute stage of the disease were asked to attend out-patient clinic after six months following COVID-19 infection diagnosis. Results: A total of 162 patients were enrolled in this study. ARB users showed significant independent association with lower fatality rate as compared to ACEI/ARB-naïve patients [OR (CI) = 0.1(0.0-0.5), p = 0.01]. The prevalence of respiratory support use and intensive care unit (ICU) admission was numerically, but not statically significant, lower among ARB users than non-ARB users. The distribution of in-hospital adverse outcome was numerically lower among ACEI users than in non ACEI users, though the association did not reach statistical significance. ARB users showed significant independent association with persistent cough [OR (CI) = 2 (1.1-10), p = 0.02]. No significant differences in other long term symptoms were found between ARB users and nonusers. On the other hand, chest pain showed higher prevalence among ACEI users than in non-ACEI users. After adjusting for baseline comorbidities, chest pain association with ACEI user was not persisted. No significant differences in other long term symptoms were found between ACEI users and nonusers. Conclusion: ARB and ACEI users showed low prevalence of in-hospital adverse outcome compared to ARB/ACEI nonusers. ARB showed significant and independent association with persistent cough.","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":"79 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2022-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80897370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Leptin in obesity and hypertension 肥胖和高血压中的瘦素

IF 0.7

Arterial Hypertension Pub Date : 2022-03-31 DOI: 10.5603/ah.a2022.0003

H. Bhat, J. Bhat, M. Bhat, Masrat Rashid, Rafi Jan, D. Afroze

引用次数: 4

Early detecting myocardial entity damage using 2D speckle tracking echocardiography through strain parameters in hypertensive patients 二维散斑跟踪超声心动图通过应变参数早期检测高血压患者心肌实体损伤

IF 0.7

Arterial Hypertension Pub Date : 2022-03-31 DOI: 10.5603/ah.a2022.0001

Thị Nguyễn Diễm, Vũ Anh Nguyễn, Lợi Doãn Đỗ, Nhân Hữu Kha, A. V. Trần, Q. T. Huynh, Bao Lam Thai Tran, Quan Nhất Kỳ Nguyễn

引用次数: 0

Drug resistant hypertension and Munchausen syndrome 耐药高血压和孟乔森综合征

IF 0.7

Arterial Hypertension Pub Date : 2022-03-31 DOI: 10.5603/ah.a2022.0002

M. Wierzowiecka, I. Smolarek, K. Niklas, A. Tykarski, Arkadiusz A. Niklas

引用次数: 0

Cardiorespiratory effect of Swedish back massage in hypertensive patients: a randomized clinical trial 瑞典式背部按摩对高血压患者心肺功能的影响:一项随机临床试验

IF 0.7

Arterial Hypertension Pub Date : 2022-02-16 DOI: 10.5603/ah.a2021.0026

M. Moghadasi, Z. Mohebbi, K. Homayouni, M. Nikoo

引用次数: 2

Effectiveness of a self-management education program on hypertension control and contributing factors in older adults: an interventional trial 对老年人高血压控制和影响因素的自我管理教育项目的有效性:一项介入性试验

IF 0.7

Arterial Hypertension Pub Date : 2021-09-30 DOI: 10.5603/AH.A2021.0025

E. Foroumandi, M. Alizadeh, Omid Nikpayam, S. Kheirouri

{"title":"Effectiveness of a self-management education program on hypertension control and contributing factors in older adults: an interventional trial","authors":"E. Foroumandi, M. Alizadeh, Omid Nikpayam, S. Kheirouri","doi":"10.5603/AH.A2021.0025","DOIUrl":"https://doi.org/10.5603/AH.A2021.0025","url":null,"abstract":"Background: One of the common disorders that can negatively affect the health status of old adults is hypertension. Self-management education is an effective method to control various disorders. This study was designed to assess the effectiveness of self-management education program on blood pressure, management of anthropometric measures, and some metabolic factors among elderly in Tabriz, Iran. Methods: 227 eligible hypertensive elderly patients from three primary health care centers of Tabriz were participated in 12 sessions of self-management education intervention conducted in 6 months from April to October 2019. Systolic (SBP) and diastolic blood pressure (DBP), serum levels of fasting blood sugar (FBS), total cholesterol (TC), and triglyceride, as well as anthropometric indices were assessed both before and at the end of the intervention. Results: The participated elderly had the mean± SD age of 64.52±5.76 years. After 6-month presence of subjects in the educational sessions, the SBP (p=0.038), body weight (p=0.012), BMI (p=0.021), FBS (0.011), and TC ( < 0.0001) were significantly decreased compared to baseline. Conclusion: Self-management educations can improve compliance of elderly to controlling factors of blood pressure such as diet and exercise. Consequently, following a healthy lifestyle can be effective in reducing a number of the hypertension risk factors.","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":"29 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80764032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0